| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Lasik Vision Institute is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Palm Springs, FL. To find more information about Lasik Vision Institute, please visit www.lasikvisioninstitute.com
Union Health Service, Inc. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MD Logic is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Palo Pinto General Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Palo Pinto General Hospital is based in Mineral Wells, TX. You can find more information on Palo Pinto General Hospital at www.ppgh.com